Key Players
Competitive Landscape
Root disease suppressors market brings together integrated crop-protection companies, microbial specialists and protein-based technology developers. Corteva Agriscience and FMC Corporation can place biological products through broader agronomy channels, while Certis Biologicals and Koppert are focusing on Bacillus, Trichoderma and soil-applied disease programs. Andermatt Group, ProFarm and Biotalys add biological, botanical or protein-based modes of action. Buyers compare approved crop and pathogen, formulation stability, mixing limit, application route and field evidence before adding a product into the program. The same strain can perform differently when soil moisture, temperature and disease pressure changes, due to which local advice remains important.
Competitive activity during 2025 moved towards regulatory approval, regional entry and lower-dose biological platforms. Biotalys received U.S. EPA approval for EVOCA in December 2025[19], Certis Biologicals received the first European authorization for NemaClean in March 2025[20] and Andermatt Group established Andermatt Italia in February 2025[21]. Biotalys also reported lower-dose field performance for BioFun-6 in March 2025[10]. These developments widen the options available to advisers; however, one approval or one field result will not remove the need for crop, disease and application fit.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| In December 2025, Biotalys received U.S. EPA approval for EVOCA as a protein-based biofungicide. | Growers need new fungal-disease modes of action. | Protein platforms are entering national registration systems. | EVOCA creates a regulatory base for later formulations. |
| In March 2025, Certis Biologicals received the first European authorization for NemaClean. | Growers need biological options for soil pests. | Biocontrol authorizations are widening in Europe. | Regional registration can support distributor-led adoption. |
| In March 2025, Biotalys reported lower-dose field performance for its BioFun-6 candidate. | Biological products must improve dose efficiency. | Pipeline development is moving toward higher potency. | Lower rates can improve handling and program fit. |
| In February 2025, Andermatt Group established Andermatt Italia S.r.l. | Biological suppliers need local market support. | Distribution and technical service are moving closer to growers. | Local presence can support registration and adviser training. |
Source: Root Disease Suppressors Market Report, 2026-2036.
Corteva Agriscience and FMC Corporation cover broad agronomy channels, while Certis Biologicals and Koppert focus on microbial disease-control programs.
Andermatt Group and ProFarm extend biological portfolios through regional networks, while Biotalys develops protein-based modes of action.
Who leads the root disease suppressors market?
Public evidence does not establish one verified market-share leader across the defined root disease suppressors market. Company position changes by approved use, formulation depth, field evidence, distribution and adviser support, hence one supplier can be stronger in a crop or region without leading the complete market.
Which companies have documented microbial disease-control capability?
Certis Biologicals and Koppert have documented microbial products for soil-borne disease programs. FMC Corporation and Corteva Agriscience connect biological products with broader crop-protection and agronomy portfolios, which can support entry through existing commercial channels.
Which companies connect biologicals with broader crop-protection channels?
Corteva Agriscience and FMC Corporation connect biological products with established crop-protection channels across several regions. Andermatt Group also uses an international distributor and subsidiary network, which can bring technical support nearer to growers.
What should buyers evaluate before product adoption?
Buyers should first check the approved crop, target pathogen, active identity, formulation stability, storage limit and mixing direction. Local trials should further show that the same application route works under the buyer's soil, moisture and treatment schedule, otherwise a registered product may still remain only a seasonal trial.
How is competition expected to change through 2036?
Competition through 2036 is expected to move towards products having national registration, local trial records, stable formulation and simpler root-zone delivery. Regional support will remain important as advisers are required to convert the product label into treatment timing, tank mix and equipment settings.
Representative Company Overview
| Company | Positioning | Verified market-relevant capability |
|---|---|---|
| Corteva Agriscience | Integrated crop-protection supplier | Bexfond biological fungicide targets Fusarium, Rhizoctonia, and Phytophthora in root-zone programs. |
| FMC Corporation | Integrated crop-protection supplier | Biological portfolio includes Bacillus-based in-furrow and seed-treatment products for soil programs. |
| Certis Biologicals | Biological crop-protection specialist | March 2025 European authorization for NemaClean expanded its biological soil-protection activity. |
| Koppert | Microbial biocontrol specialist | July 2026 Trianum trials covered granular and water-dispersible formulations in lettuce. |
| Andermatt Group | Biological crop-protection specialist | February 2025 establishment of Andermatt Italia expanded regional biological support. |
| ProFarm | Naturally derived crop-protection platform | Regalia and related naturally derived products support integrated disease-management programs. |
| Biotalys | Protein-based crop-protection developer | December 2025 U.S. EPA approval for EVOCA validated its protein-based biofungicide platform. |
Research Methodology
The competitive assessment covers companies having public evidence of products, approvals, trials, distribution or technical activity within the defined root disease suppressors market. Evidence is taken from regulator records, company announcements, product labels, technical documents and current corporate filings. Developments are included where they show registration, field result, regional expansion, partnership or portfolio change directly connected with biological disease control. Companies are compared through product depth, application fit, current activity and geographic reach. Conventional chemical fungicides, generic biostimulants without disease claims and unrelated pest products are excluded. Hence, the company coverage explains competitive position but does not establish a market-share ranking.
